SSY Group Gains Key Approval for Paracetamol Tablets

SSY Group (HK:2005) has released an update.

SSY Group Limited has successfully gained approval from China’s National Medical Products Administration for its Paracetamol Tablets, adding a new 0.5g specification to its lineup. Both the 0.3g and 0.5g versions have passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs, marking significant progress in the company’s product development efforts. This advancement could potentially enhance SSY Group’s position in the pharmaceutical market.

For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.